A Study of NXP900 in People with Cancer

Full Title

A Phase 1 Clinical Study of NXP900 in Subjects with Advanced Cancers

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Paul Paik’s office at 646-608-3759.

Protocol
26-169
Phase
Phase I (phase 1)
Disease Status
Relapsed or Refractory
Investigator
Paul K. Paik
Co-Investigators
Helena A. Yu
Diseases
Lung Cancer › Lung Cancer, Non-Small Cell
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT05873686
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description